Technical Analysis for AXGT - Axovant Sciences Ltd.

Grade Last Price % Change Price Change
grade C 7.69 0.92% 0.07
AXGT closed up 0.92 percent on Friday, September 13, 2019, on 35 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical AXGT trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
NR7 Range Contraction 0.92%
Upper Bollinger Band Walk Strength 0.92%
Overbought Stochastic Strength 0.92%
Upper Bollinger Band Touch Strength 0.92%
Pocket Pivot Bullish Swing Setup -0.65%
Upper Bollinger Band Walk Strength -0.65%
Above Upper BB Strength -0.65%

Older signals for AXGT ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Axovant Sciences is a clinical-stage gene therapy company focused on developing a pipeline of innovative product candidates for debilitating neurological and neuromuscular diseases. The company’s current pipeline of gene therapy candidates targets GM1 gangliosidosis, GM2 gangliosidosis (including Tay-Sachs disease and Sandhoff disease), Parkinson’s disease, oculopharyngeal muscular dystrophy (OPMD), amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. Axovant is focused on accelerating product candidates into and through clinical trials with a team of experts in gene therapy development and through external partnerships with leading gene therapy organizations.
Rare Diseases Gene Therapy Amyotrophic Lateral Sclerosis Parkinson’s Disease Frontotemporal Dementia Lipid Storage Disorders Oculopharyngeal Muscular Dystrophy Axovant Sciences Gangliosidosis Gm1 Gm1 Gangliosidosis Gm2 Gangliosidoses Gm 2 Gangliosidosis Gm2 Gangliosidosis Neurological And Neuromuscular Diseases Sandhoff Disease Tay Sachs Disease Tay–Sachs Disease
Is AXGT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 20.8
52 Week Low 3.81
Average Volume 193,850
200-Day Moving Average 8.4823
50-Day Moving Average 6.8452
20-Day Moving Average 6.953
10-Day Moving Average 7.221
Average True Range 0.472
ADX 22.08
+DI 22.7993
-DI 10.0444
Chandelier Exit (Long, 3 ATRs ) 6.474
Chandelier Exit (Short, 3 ATRs ) 7.656
Upper Bollinger Band 7.7519
Lower Bollinger Band 6.1541
Percent B (%b) 0.96
BandWidth 22.980009
MACD Line 0.2419
MACD Signal Line 0.1381
MACD Histogram 0.1039
Fundamentals Value
Market Cap 826.86 Million
Num Shares 108 Million
EPS -2.10
Price-to-Earnings (P/E) Ratio -3.66
Price-to-Sales 0.00
Price-to-Book 2.66
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.40
Resistance 3 (R3) 8.36 8.09 8.28
Resistance 2 (R2) 8.09 7.91 8.11 8.24
Resistance 1 (R1) 7.89 7.80 7.99 7.93 8.20
Pivot Point 7.62 7.62 7.67 7.64 7.62
Support 1 (S1) 7.42 7.44 7.52 7.46 7.18
Support 2 (S2) 7.15 7.33 7.17 7.14
Support 3 (S3) 6.95 7.15 7.10
Support 4 (S4) 6.99